About Apcegen
Apcegen is a Healthcare company based in Bengaluru (India) founded in 2010 by Amita Vyas. Peptide therapies for cancer and autoimmune diseases are developed. Apcegen has raised $19.45 thousand across 2 funding rounds from investors including Indian Institute of Technology Kanpur and Department of Biotechnology. Apcegen was last valued at $383.18 thousand in August 2015. Its Indian entity Apcegen Technologies Private Limited reported revenue of ₹1.17 Cr. Its focus areas include Diversified Pharmaceuticals, Life Sciences, Immunotherapy and Antibody.
Company details
Apcegen was founded in 2010 in Bengaluru, India, within the biotechnology sector. Peptide-based treatments for cancer and autoimmune conditions are developed by the company. Protein-based chips for diagnosing and treating diseases such as cancer-related anaemia, renal failure, and diabetes are also created. Operations focus on therapeutic innovations and diagnostic tools, with activities centered in India.
- Headquarters Bengaluru, India
- Founders Amita Vyas
- SectorsHealthcare
- Email••••••••
- Website apcegen.com
- Social LinkedIn
- Legal Name Apcegen Technologies Private Limited
- Date of Incorporation 19 Apr, 2010
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.17 Cr
FY 2025 · -8% YoY
- Net Profit₹42.8 Lakh
FY 2025 · 37% margin
- EBITDA₹64.6 Lakh
FY 2025 · 55% margin
- Total Equity Funding$19.45K (USD)
in 2 rounds
- Latest Funding Round$19.45K (USD), Seed
Aug 2015
- Investors
Associated legal entities of Apcegen
Apcegen operates through Apcegen Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Apcegen Technologies Private Limited CIN U85100KA2010PTC053272 | Active | 19 Apr 2010 | Bangalore, Karnataka | ₹1.2 Cr | 3 | View details |
Funding Insights of Apcegen
Apcegen has successfully raised a total of $19.45K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $19.45 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19,454
- Total Rounds 2
- Last Round Seed — $19,454
- Investors Count 2
All 2 funding rounds of Apcegen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $19,454 | Seed | $383,181 | Indian Institute of Technology Kanpur | – |
| Jun 2015 | Grant | – | – |
Last known valuation $383,181 (Aug 2015). 2 investors in total: 2 institutional.
Investors in Apcegen
Apcegen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Indian Institute of Technology Kanpur and Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple engineering courses and degrees are offered at the institute. | 1959 | iitk.ac.in | Kanpur, India | |
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India |
Investor details for Apcegen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Apcegen Technologies Private Limited (Apcegen)
Apcegen Technologies Private Limited is the primary company behind Apcegen. The board of Apcegen Technologies Private Limited currently have 3 directors; the longest-serving is Amita Ashutosh Vyas, appointed in 2010. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amita Ashutosh Vyas DIN 02769029 | Director | 19 Apr 2010 | 16 yrs 6 mo | Apcegen Technologies Private Limited |
| Sandeep Shandilya DIN 10332631 | Director | 25 Sep 2023 | 3 yrs 1 mo | Apcegen Technologies Private Limited |
| Ashutosh Vyas DIN 02858842 | Whole-Time Director | 16 Jan 2026 | 9 mo | Apcegen Technologies Private Limited |
People of Apcegen
1 people are tracked at Apcegen (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Apcegen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Apcegen
Figures of Apcegen Technologies Private Limited, the primary company behind Apcegen, for FY 2025. Revenue was ₹1.17 Cr (-8% year on year). Net profit was ₹42.8 Lakh (37% margin). EBITDA was ₹64.6 Lakh (55% margin).
- ₹1.17 CrRevenue · FY 2025 · -8% YoY
- ₹42.8 LakhNet profit · 37% margin
- ₹64.6 LakhEBITDA · 55% margin
- ₹10.5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Apcegen Technologies Private Limited are on its company page.
Detailed financial statements for Apcegen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Apcegen
3 dated milestones of Apcegen across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Apcegen is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $19K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apcegen
Apcegen was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Apcegen is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Apcegen is a funded company, having raised a total of $19.45K across 2 funding rounds to date.
The primary company behind Apcegen, Apcegen Technologies Private Limited, reported revenue of ₹1.17 Cr for FY 2025, down 8% year on year.
Apcegen was founded in 2010 in Bengaluru, India, within the biotechnology sector. Peptide-based treatments for cancer and autoimmune conditions are developed by the company. Protein-based chips for diagnosing and treating diseases such as cancer-related anaemia, renal failure, and diabetes are also created. Operations focus on therapeutic innovations and diagnostic tools, with activities centered in India.
Apcegen has 2 investors. Key investors include Indian Institute of Technology Kanpur, and Department of Biotechnology.
The valuation of Apcegen is $383.18K as of Aug 2015.
Apcegen operates through Apcegen Technologies Private Limited.
The legal entities of Apcegen currently have 3 directors, including Sandeep Shandilya, Amita Ashutosh Vyas, Ashutosh Vyas.